Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 366.19 million as of March 9, 2026. Its market cap has increased by 71.15% in one year.

Market Cap

366.19M

Enterprise Value

374.94M

Revenue

55.93M

Ranking

n/a

PE Ratio

15.86

Stock Price

17.56

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 366.19M, an increase of 18.49%. That is a compound annual growth rate of 0.89%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	366.19M	-23.08%
Dec 30, 2025	476.07M	173.36%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Santhera Pharmaceuticals Holding AG	213.08M
Basilea Pharmaceutica AG	639.16M
Idorsia	887.82M
BioVersys AG	149.71M
Molecular Partners AG	145.86M
Xlife Sciences AG	127.46M
EvoNext Holdings	6.98M
Addex Therapeutics	5.83M

Market Cap Rankings